Pineapple Express Cannabis (PNXP) Receivables - Other (2021 - 2023)
Pineapple Express Cannabis' (PNXP) quarterly Receivables - Other came in at $88298.0 in Q4 2023, down 2.21% quarter-over-quarter from $90298.0 in Q3 2023.
Pineapple Express Cannabis (PNXP) Receivables - Other (2021 - 2023) Analysis & Trends
Pineapple Express Cannabis has disclosed Receivables - Other across 2 years of filings, most recently posting $88298.0 for Q4 2023.
- Receivables - Other for Q4 2023 came in at $88298.0, changed N/A year-over-year; the trailing twelve-month figure through Oct 2023 was $88298.0 (changed N/A YoY), and the FY2021 annual result was $12100.0, changed N/A from the prior year.
- Receivables - Other came in at $88298.0 for Q4 2023 at Pineapple Express Cannabis, down from $90298.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $112960.0 in Q2 2023 to a low of $12100.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Pineapple Express Cannabis | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2023 | 88,298.00 |
| Oct 31, 2023 | 88,298.00 |
| Jul 31, 2023 | 90,298.00 |
| Jul 31, 2023 | 90,298.00 |
| Apr 30, 2023 | 112,960.00 |
| Apr 30, 2023 | 112,960.00 |
| Jan 31, 2021 | 12,100.00 |
| Jan 31, 2021 | 12,100.00 |